Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Treasury Shares (2021 - 2023)

Historic Treasury Shares for CureVac (CVAC) over the last 3 years, with Q1 2023 value amounting to -$369229.6.

  • CureVac's Treasury Shares rose 8937.39% to -$369229.6 in Q1 2023 from the same period last year, while for Mar 2023 it was -$369229.6, marking a year-over-year increase of 8937.39%. This contributed to the annual value of $1.5 million for FY2022, which is 7729.37% down from last year.
  • CureVac's Treasury Shares amounted to -$369229.6 in Q1 2023, which was up 8937.39% from $1.5 million recorded in Q4 2022.
  • In the past 5 years, CureVac's Treasury Shares registered a high of $6.7 million during Q4 2021, and its lowest value of -$3.6 million during Q2 2021.
  • Moreover, its 3-year median value for Treasury Shares was -$1.1 million (2023), whereas its average is -$395660.4.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 60262.84% in 2022, then surged by 8937.39% in 2023.
  • Quarter analysis of 3 years shows CureVac's Treasury Shares stood at $6.7 million in 2021, then tumbled by 77.29% to $1.5 million in 2022, then plummeted by 124.44% to -$369229.6 in 2023.
  • Its Treasury Shares was -$369229.6 in Q1 2023, compared to $1.5 million in Q4 2022 and -$1.7 million in Q3 2022.